Skip to main content
. 2022 Dec 19;14(24):6261. doi: 10.3390/cancers14246261

Table 2.

Relationship between cancer subtype and pathologic complete response (N, %).

Cancer Subtype Non-pCR
(n = 274, 82.8)
pCR
(N = 57, 17.2)
Total
(N = 331, 100)
p-Value
HR(+), HER2(−) 137 (93.8) 9 (6.2) 146 (100) <0.001
HR(+), HER2(+) 60 (75.9) 19 (24.1) 79 (100)
HR(−), HER2(+) 36 (66.7) 18 (33.3) 54 (100)
Triple-negative 41 (78.8) 11 (21.2) 52 (100)

pCR: pathologic complete response; HR: hormone receptor; HER2: human epidermal growth factor receptor 2.